Neal J. Meropol

Case Western Reserve University, Flatiron Health (United States)

Papers

Total Citations

H-Index

About

Neal J. Meropol is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with kidney cancer, particularly through the study of partial nephrectomy techniques and health disparities. His major contributions center on evaluating how surgical approach—open, laparoscopic, or robotic—affects critical outcomes like surgical margin status in patients with small renal masses (clinical T1a). In a landmark 2015 study using the National Cancer Database (NCDB), Meropol demonstrated significant variation in positive surgical margin rates by approach, providing evidence that influences surgical decision-making for nephron-sparing surgery. His work has garnered over 77 citations, reflecting its impact on clinical practice. Notably, Meropol has also investigated the intersection of race and surgical outcomes; his 2017 study on robotic partial nephrectomy for T1 renal cell carcinoma revealed that African American patients had higher positive margin rates, highlighting persistent disparities in cancer care. By combining population-based data analysis with a focus on equity, Meropol’s research not only advances surgical technique but also addresses systemic barriers to optimal treatment, making him a key voice in urologic oncology and health services research.